A Clinical Trial to study the effect of the Drug Pungampoo Chooranam in patients with High Blood Sugar Level.

A CLINICAL STUDY ON MADHUMEGAM (DIABETES MELLITUS)WITH THE EVALUATION OF SIDDHA DRUG " PUMGAMPOO CHOORANAM "

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/02/007956

Enrollment

Registered

2017-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetes mellitus type - 2

Interventions

Intervention1: Pungampoo Chooranam: Dose - 2gms twice a day adjuvant-hot water. No of days - 48 Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Blood glucose(F) â??upto 120 mg/dl 2. Blood glucose(pp)-upto 280 mg/dl 3. HBA1C - 6.5 to 8% 4. Polyuria 5. Polydipsia 6. Polyphagia 7. Nocturia 8. Noticeable weight loss. 9. Fatigue 10.Lethargy 11.Tiredness

Exclusion criteria

Exclusion criteria: 1. Insulin Dependent Diabetes Mellitus 2. Cardiovascular Disease 3. Diabetic Nephropathy 4. Diabetic Retinopathy 5. Pregnant women 6. Lactating mothers 7. Tuberculosis affected individuals.

Design outcomes

Primary

Measure	Time frame
Mainly assessed by : Reduction in clinical symptoms and comparing before and after blood sugar level of retreatment Timepoint: 48 days	—

Secondary

Measure	Time frame
Mainly assessed by comparing safety parameters before and after treatmentTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr J NISHA

Government Siddha Medical College, Arumbakkam, Chennai-600106.

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026